Tumor-induced osteomalacia (TIO) is a rare condition associated with hypophosphatemia, myopathy, and systemic bone demineralization caused by renal phosphate wasting in conditions of excessive production of fibroblast growth factor 23 (FGF23) by neoplasmatic, most often, benign lesions. This evidence concerns the gene FGF23 and myopathy.